Vol. XVIII · Free shipping $75+ · Read the collection
Login Register
Feature · Product Review
kras mutation and glutathion

kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports The KRAS-G12D mutation induces metabolic

The KRAS G12D mutation induces metabolic vulnerability in B cell acute lymphoblastic leukemia ScienceDirect KRAS in Non Small Cell Lung Cancer Encyclopedia MDPI Uncovering new therapeutic targets for a common KRAS mutation behind cancer The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy PMC Targeting KRAS mutant stomach colorectal tumors by disrupting the ERK2 p53 complex ScienceDirect

SKU: 55323947782 · From hgidocs.co

4.9
USD26.39 USD48.39

Pay in 4 interest-free payments of $6.60 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Leptin resistance and obesity

kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports The KRAS-G12D mutation induces metabolic

10.1046/j.1471-4159.1994.62010045.x J

kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports The KRAS-G12D mutation induces metabolic

Kwon et al., 2010)

kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports The KRAS-G12D mutation induces metabolic

Metalorganic framework derived nanozymes in biomedicine

kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports The KRAS-G12D mutation induces metabolic

The regulatory factors of different RCD pathways remain highly attractive therapeutic targets in the context of related liver diseases

kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports The KRAS-G12D mutation induces metabolic
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products

Frontiers

US$ 24.54

Min. order: 1 piece

4.8 (17 reviews)

Sold : Login>>